(EMAILWIRE.COM, January 15, 2019 ) The ultrasound probe disinfection market was valued at USD 260.7 million in 2017 and is estimated to grow at a CAGR of 21.1% during the forecast period, to reach USD 819.1 million by 2023. Factors such as the increasing number of ultrasound imaging procedures, rising incidence of hospital-acquired infections due to the improper reprocessing of ultrasound probes, increasing adoption of high-level disinfection systems for critical and semi-critical ultrasound probes, and technological advancements in ultrasound probes are driving the growth of this market.

https://www.marketsandmarkets.com/Market-Reports/ultrasound-probe-disinfection-market-106309326.html

The major players in the market are Nanosonics (Australia), CIVCO Medical Solutions (US), Tristel (UK), Ecolab (US), Germitec (France), Parker Laboratories (US), Schülke & Mayr (Germany), CS Medical (US), Virox Technologies (Canada), STERIS (UK), Advanced Sterilization Products (US), and Metrex Research (US).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106309326

The market is segmented based on product, process, type of probe, end user, and region. Based on product, the market is segmented into instruments, consumables, and services. The consumables segment is expected to account for the largest share of the market in 2018. The market, by process, is segmented into high-level disinfection and intermediate/low-level disinfection. The high-level disinfection segment is expected to account for a larger share of the market in 2018. This can be attributed to the growing number of ultrasound imaging procedures in surgeries and the increasing demand for automated disinfection systems for the high-level disinfection of TEE and endocavitary transducers.

Geographically, the global market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to account for the largest share of the market in 2018. Also, this regional market is estimated to grow at the highest CAGR during the forecast period. This can be attributed to the increasing number of transvaginal, transrectal, abdominal, and intraoperative ultrasound procedures; growing number of transesophageal echocardiography (TEE) and ultrasound-guided interventional procedures (biopsies and venous access); rising adoption of high-level disinfectants; and the presence of leading market players in this region. However, the high cost of automated probe reprocessors and the reluctance to shift from manual disinfection methods to automated probe reprocessors are restraining the growth of this market.